Use Of Retroviral Markers To Identify Efficacy Of Purging And Origin Of Relapse Following Autologous Bone-Marrow And Peripheral-Blood Cell Transplantation In Indolent-B Cell Neoplasms (Follicular Non-Hodgkins-Lymphoma Or Chronic Lymphocytic-Leukemia (Cll) Patients)

Human Gene TherapyVol. 4, No. 6 News and CommentsUse of Retroviral Markers to Identify Efficacy of Purging and Origin of Relapse Following Autologous Bone Marrow and Peripheral Blood Cell Transplantation in Indolent B Cell Neoplasms (Follicular Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (CLL) Patients). The University of Texas M.D. Anderson Cancer CenterStudy Chairman Albert Deisseroth, Study Collaborators Hagop Kantarjian, Richard Champlin, Fernando Cabanillas, Michael Keating, Chris Reading, Borje Andersson, David Claxton, Bud Robertson, Susan Escudier, Michael Andreeff, Susan O'Brien, Steven Kornblau, Debra Ellerson, Elie Hanania, and Siqing FuStudy Chairman Albert DeisserothSearch for more papers by this author, Study Collaborators Hagop KantarjianSearch for more papers by this author, Richard ChamplinSearch for more papers by this author, Fernando CabanillasSearch for more papers by this author, Michael KeatingSearch for more papers by this author, Chris ReadingSearch for more papers by this author, Borje AnderssonSearch for more papers by this author, David ClaxtonSearch for more papers by this author, Bud RobertsonSearch for more papers by this author, Susan EscudierSearch for more papers by this author, Michael AndreeffSearch for more papers by this author, Susan O'BrienSearch for more papers by this author, Steven KornblauSearch for more papers by this author, Debra EllersonSearch for more papers by this author, Elie HananiaSearch for more papers by this author, and Siqing FuSearch for more papers by this authorPublished Online:19 Mar 2008https://doi.org/10.1089/hum.1993.4.6-821AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited ByIn Vitro Selection for K562 Cells with Higher Retrovirally Mediated Copy Number of Aldehyde Dehydrogenase Class-1 and Higher Resistance to 4-Hydroperoxycyclophosphamide20 March 2008 | Human Gene Therapy, Vol. 9, No. 5Adenovirus mediated gene transfer to intestinal epithelial cells as a potential approach for oral delivery of peptides and proteinsJournal of Controlled Release, Vol. 46, No. 1-2Bone Marrow and Clinical Gene Therapy27 March 2009 | Journal of Hematotherapy, Vol. 4, No. 6A Phase I Study of Autologous Bone Marrow Transplantation with Stem Cell Gene Marking in Multiple Myeloma. The Toronto Hospital, Ontario, Canada19 March 2008 | Human Gene Therapy, Vol. 6, No. 1Retroviral-mediated gene transfer into human myeloma cellsBritish Journal of Haematology, Vol. 88, No. 2 Volume 4Issue 6Dec 1993 InformationCopyright 1993, Mary Ann Lieber, Inc.To cite this article:Study Chairman Albert Deisseroth, Study Collaborators Hagop Kantarjian, Richard Champlin, Fernando Cabanillas, Michael Keating, Chris Reading, Borje Andersson, David Claxton, Bud Robertson, Susan Escudier, Michael Andreeff, Susan O'Brien, Steven Kornblau, Debra Ellerson, Elie Hanania, and Siqing Fu.Use of Retroviral Markers to Identify Efficacy of Purging and Origin of Relapse Following Autologous Bone Marrow and Peripheral Blood Cell Transplantation in Indolent B Cell Neoplasms (Follicular Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (CLL) Patients). The University of Texas M.D. Anderson Cancer Center.Human Gene Therapy.Dec 1993.821-834.http://doi.org/10.1089/hum.1993.4.6-821Published in Volume: 4 Issue 6: March 19, 2008PDF download